ArticleInternational journal of nanomedicine2025
LbL-Antibody Embedded Gold Mesh: An Effective Method for Early Detection of Circulating Tumor Cells.
Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The importance of early cancer diagnosis has been recognized for decades, driving the demand for technological advancements and novel strategies for cancer detection. The conventional detection of circulating tumor cells (CTCs) often relies on size-based separation to distinguish CTCs from other blood cells. However, this method frequently leads to significant cell congestion and poorly recognizable fluorescent images, which inevitably reduces the sensitivity and specificity of CTC detection. Most CTC current separation devices with a cell filtration process have a cell capture efficiency ranging from 50% to 80% in clinical application. Methods: We constructed a flexible antibody network on the surface of gold-plated iron meshes with a pore size of 20 μm using the layer-by-layer (LbL) assembly technique. These meshes were then used to enrich MCF7 cells and CTCs in 10 clinical blood samples from breast cancer patients. Results and the Conclusion: This antibody network reduced the effective pore size, thereby improving both capture efficiency and specificity for CTCs. In a cell line separation study, meshes with a trilayered antibody network demonstrated a capture efficiency of 65% compared to 26% for those with a single layer. In tests using clinical samples, the trilayered antibody network achieved 100% accuracy, whereas the single-layer configuration only reached 40%. The multilayered antibody network shows strong potential for enhancing widely used immunosensors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.